IndraLab

Statements


CDK1 activates USP29. 1 / 1
| 1

reach
"More importantly, the genetic ablation or the pharmacological inhibition of CDK1 could deactivate USP29 and subsequently destabilize TWIST1, thereby largely mitigating EMT, CSC self‐renewal, and metastasis, and sensitizing TNBC cells to chemotherapy."